H.D. Smith signs prime vendor agreement with U.S.-based Nigerian pharmacy group
CINCINNATI and SPRINGFIELD, Ill. A large group of Nigerian-owned independent retailers has struck a new, three-year prime vendor agreement with H.D. Smith, a leading national pharmaceutical wholesaler.
H.D. Smith and the Nigerian Association of Pharmacists and Pharmaceutical Scientists in America said the deal would bolster both groups. Under terms of the contract, H.D. Smith will become the primary supplier of pharmaceutical products for the more than 100 U.S. pharmacies that are NAPPSA members. The supply agreement begins immediately and extends through June 30, 2013.
“We are excited and proud of this accomplishment, and hope it is only the beginning of more to come,” said NAPPSA Nnodum Iheme. “Since success breeds success, we anticipate more Nigerian-owned pharmacies to join or partner with NAPPSA.”
H.D. Smith chairman and CEO Dale Smith also expressed satisfaction with the agreement. “The decision to select a primary vendor does not come lightly and demands close inspection of services, programs and reputation,” Smith said. “We seek to enhance NAPPSA members’ success.”
NAPPSA is an umbrella organization of Nigerian pharmacists, pharmaceutical scientists, allied scientists and academics in the Americas. “Among other objectives, NAPPSA fosters cooperative efforts among relevant educational, research, industrial, commercial and governmental entities; propagates critical information in the medical, biological, pharmaceutical and related healthcare-technology fields, for the optimization of health outcomes,” the group noted in a statement.
H.D. Smith markets itself as “the largest privately held national full-line, full-service wholesaler that provides a complete line of pharmaceuticals, OTCs, HBAs, home healthcare products, durable medical equipment, seasonal merchandise and a wide array of marketing programs to retail pharmacies, regional chains and health systems.”
Vicks Starry Night humidifier hits retail shelves
NEW YORK Kaz on Tuesday announced the launch of its Vicks Starry Night humidifier, a product that releases cool moisture into the air for temporary relief of congestion and coughs, and features a built-in, independently controlled projector so that parents have the option to turn off the lights once their child has fallen asleep without turning off the humidifier altogether.
With the Vicks Starry Night humidifier, parents will be able to create a virtual galaxy on their child’s bedroom ceiling.
Arecently released scientific white paper suggested humidifiers may play an important role in reducing the survival of the flu virus on both surfaces and in the air. The research suggested that homes kept between 40% and 60% relative humidity are likely to have fewer flu viruses lingering in the air and on such commonly touched surfaces as sink faucets, door handles and countertops.
Best used in medium-sized rooms, the Vicks Starry Night humidifier operates between 18 hours and 24 hours on a 1-gallon tank. The product’s built-in scent pad heater works with Vicks Soothing Vapors VapoPads.
The Vicks Starry Night Cool Moisture humidifier (V3700) has a suggested retail price of $54.99, and currently is available through Toys"R"Us, Kmart, Walgreens and on Amazon.com.
Rexam’s Pill Timer seeks to improve medication adherence
PERRYSBURG, Ohio Rexam is marketing a programmable pill timer that fits on its prescription vials that was developed under a partnership with Med Time Technology.
The two companies announced Tuesday the introduction of the Pill Timer, which uses software that can be programmed with audio and visual alerts to help people properly take their prescription medications. The Detroit-based Henry Ford Health System is one of the first healthcare organizations to adopt the product.
“The use of the Pill Timer will enable Henry Ford to help chronically ill patients manage their medication more effectively,” Henry Ford director of pharmacy Steve Duda said. “It’s an important breakthrough for our patients.”
Every year, poor medication management is estimated to cost the U.S. economy $300 billion and claim 300,000 lives, Rexam said.